ALS Patients

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive neurodegenerative disease impacting nerve cells in the brain and spinal cord, reducing muscle function and control. ALS can be traced to mutations in more than 25 different genes and is often caused by a combination of multiple sub-forms of the condition. Cases usually cannot be predicted, although a small percentage are inherited. ALS has a devastating impact on patients and families. ALS patients’ average life expectancy is three years, and there is currently no cure for the disease.

Through DNA analysis and clinical studies, we now know that there are several distinct ALS pathologies that need to be addressed to achieve success. The majority of ALS patients do not benefit from currently available treatments, and QurAlis is working to change this through a precision medicine approach. Our researchers take cells directly from ALS patients and use them to model the disease in the lab to identify potential avenues to treatment. As we advance our therapeutic programs and continue to investigate new treatment options, we keep the ALS patients and families top-of-mind as we fight to conquer this devastating disease.

There are many patient organizations dedicated to supporting individuals with ALS and their loved ones, including:

We want to hear from you!

Whether you or a loved one is battling ALS or another neurodegenerative disease, or you want to support the fight against these debilitating diseases, we want to hear from you. If you have a question, please fill out the form below and we will get back to you as soon as possible.

For questions about QurAlis clinical trials, please contact:

  • This field is for validation purposes and should be left unchanged.